News

Filter

Current filters:

None

82 to 91 of 97511 results

EC approves AbbVie’s Viekirax + Exviera for hepatitis C

EC approves AbbVie’s Viekirax + Exviera for hepatitis C

16-01-2015

The European Commission has granted marketing authorizations for US drugmaker AbbVie’s all-oral, short-course,…

AbbVieAnti-viralsEuropeExvieraPharmaceuticalRegulationViekirax

Amgen trials show no differences in quality of life between the FOLFOX regimens with or without Vectibix

Amgen trials show no differences in quality of life between the FOLFOX regimens with or without Vectibix

16-01-2015

USA-based Amgen, the world’s leading independent biotech firm, says that Phase II and Phase III studies…

AmgenBiotechnologyOncologyResearchVectibix

Court orders SIGA to pay $195,000 in case brought by PharmAthene for Tecovirimat

Court orders SIGA to pay $195,000 in case brought by PharmAthene for Tecovirimat

16-01-2015

The Delaware Court of Chancery has entered its Final Order and Judgment in the case brought by US pharma…

Anti-viralsLegalPharmaceuticalPharmAtheneSIGA TechnologiesTecovirimatUSA

Novogen identifies family of compounds to promote brain stem cell growth

Novogen identifies family of compounds to promote brain stem cell growth

16-01-2015

Australian biotech firm Novogen has announced an important discovery in its regenerative medicine program…

BiotechnologyNeurologicalNovogenResearch

UK NICE recommends hepatitis C drugs Sovaldi and Olysio

UK NICE recommends hepatitis C drugs Sovaldi and Olysio

16-01-2015

In final draft guidance issued today, England health costs watchdog the National Institute for Health…

Anti-viralsBiotechnologyGilead SciencesJanssenJohnson & JohnsonOlysioPricingRegulationSovaldiUK

Depomed pays over $1 billion for US rights to Janssen’s Nucynta franchise

Depomed pays over $1 billion for US rights to Janssen’s Nucynta franchise

16-01-2015

US specialty drugmaker Depomed has entered into a definitive agreement to acquire the US rights to the…

DepomedGrunenthalJanssenJohnson & JohnsonLicensingNeurologicalNucyntaPharmaceuticalUSA

AstraZeneca unit in deal with Omnis Pharma for oncolytic viruses in immuno-oncology

15-01-2015

Anglo-Swedish pharma major AstraZeneca’s biologics R&D subsidiary MedImmune has entered into a licensing…

AstraZenecaBiotechnologyLicensingMedImmuneOmnis PharmaceuticalsOncology

GlobalData believes Shire-NPS deal to be 'robust'

GlobalData believes Shire-NPS deal to be 'robust'

15-01-2015

Ireland-headquartered drugmaker Shire’s deal to acquire NPS Pharmaceuticals is ‘robust’, according…

GattexGlobalDataMergers & AcquisitionsNatparaNPS PharmaceuticalsPharmaceuticalRare diseasesResearchShire

82 to 91 of 97511 results

Back to top